Introduction
============

Endogenous endophthalmitis is a rare and visually devastating disease characterized by hematogenous dissemination of micro-organisms from a focus in the body, that in turn cross the blood-brain barrier and inoculate the intraocular tissues. Endogenous endophthalmitis has been well described in adults, but few cases have been reported in the neonatal population.

In a large case series of endophthalmitis occurring in children and young adults, the most common endophthalmitis category was in the setting of trauma.[@b1-opth-6-733] In contrast, endophthalmitis in infants is mostly endogenous and results perinatally from vertical transmission or postnatally from contaminated intravascular catheters, respiratory equipment, or caregivers.[@b2-opth-6-733]--[@b6-opth-6-733] The most commonly described pathogens in neonatal endophthalmitis are Candida species, group B streptococci, *Pseudomonas aeruginosa*, and other Gram negative bacteria.[@b7-opth-6-733]--[@b11-opth-6-733]

Neonates in the neonatal intensive care unit (NICU) with a diagnosis of septicemia or fungemia are routinely screened to rule out ocular involvement. Risk factors of developing endophthalmitis in neonates include candidemia, bacteremia, retinopathy of prematurity, respiratory disorder, blood transfusion, fetal hemorrhage, and low birth weight.[@b12-opth-6-733]

The mainstay of treatment for endogenous endophthalmitis includes systemic antimicrobials with adjuvant intravitreal injections and pars plana vitrectomy in selected patients. In general, the visual prognosis is unfavorable, and the mortality rate is associated with virulence of the organisms causing underlying neonatal septicemia. Visual outcomes are generally more favorable among those surviving candidemia when compared with bacterial septicemia.[@b13-opth-6-733]--[@b17-opth-6-733]

Materials and methods
=====================

A retrospective review of the medical records was conducted for all patients admitted to the NICU at Jackson Memorial Hospital between March 1, 2002 and March 1, 2007. This study was approved by the internal review boards at the University of Miami Miller School of Medicine and Jackson Memorial Hospital, and all procedures were performed in accordance with the 1951 Declaration of Helsinki.[@b18-opth-6-733]

The neonatology division of Jackson Memorial Hospital maintains a clinical database of all newborns admitted to the NICU. A pediatric retina specialist (AMB) conducted a dilated examination of the fundus when blood, urine, wound, or cerebrospinal fluid cultures confirmed systemic infection or as screening for retinopathy of prematurity. Indirect ophthalmoscopy with or without scleral depression was performed one hour after pupillary dilation. No infant was too ill to undergo complete ophthalmoscopic examination.

Neonatal patients with endophthalmitis were identified clinically by anterior segment findings and by the presence of characteristic vitreous opacities or chorioretinal infiltrates. Septicemia was confirmed in conjunction with the neonatologists by clinical signs of sepsis and positive blood, urine, cerebrospinal fluid, vitreous, or wound cultures, or polymerase chain reaction. Broad-spectrum antibiotics (ampicillin and gentamicin) and/or antifungals (fluconazole or amphotericin) were initiated when sepsis was suspected, and intravascular catheters were changed if blood cultures were positive. Intravitreal antibiotics and/or antifungals and vitreous surgery were performed when the initial clinical signs were severe or the vitritis worsened despite systemic treatment.

Results
=======

Of 4323 infants admitted to the NICU at Jackson Memorial Hospital during the 5-year study period, seven eyes of six infants (two males, four females) had endophthalmitis. Mean follow-up was 3.5 years. Four infants were transferred from an outside NICU for worsening systemic and ocular complications. Four patients were born prematurely with a mean gestational age of 27.5 weeks and a mean birth weight of 1153 g (three patients weighed ≤1000 g).

The four preterm infants had multiple comorbidities associated with prematurity, including bronchopulmonary dysplasia, hydrocephalus, intraventricular hemorrhage, anemia, rickets, and hypothyroidism. Each was screened for development of retinopathy of prematurity, which was found in two patients and required treatment. Two patients had tunica vasculosa lentis.

All six infants showed constitutional signs of infection, including fever, poor feeding, lethargy, worsening respiratory status, or bradycardia. Ophthalmologic consultation was sought immediately in five of six infants, and in these cases, the ophthalmologist used indirect ophthalmoscopy to confirm the diagnosis on the same day. The one infant with delayed consultation was constitutionally improving after three weeks of liposomal amphotericin B, and ophthalmology consultation was sought only after corneal edema and leukocoria was noted in the right eye.

The mean number of postnatal days to time of positive culture was 34 (range 21--43). Cultures or polymerase chain reaction identified the pathogens in all cases. Although all patients were tested, only two patients had positive blood and urine cultures. Diagnostic extraocular cultures were obtained invasively from multiple sites in three patients, two from hepatic abscesses, and one from pleural fluid. Anterior chamber polymerase chain reaction was positive in one patient. Ocular cultures were obtained in five patients, four from vitreous cultures, and two from removed ocular contents (enucleation and evisceration specimens). Cultures grew from multiple sites in four patients. *Candida albicans* was the causative organism in four patients ([Figure 1](#f1-opth-6-733){ref-type="fig"}). *Pseudomonas aeruginosa* and herpes simplex virus type 2 each caused endophthalmitis in one patient ([Figure 2](#f2-opth-6-733){ref-type="fig"}). All cases of *C. albicans* were sensitive to fluconazole, and the case of *P. aeruginosa* was sensitive to piperacillin and third-generation cephalosporins. Treatment and outcomes are summarized in [Table 1](#t1-opth-6-733){ref-type="table"}.

Because long-term follow-up was not possible in all patients, visual acuity data cannot be presented. Of the seven eyes, two had very poor outcomes (one enucleation ([Figure 3](#f3-opth-6-733){ref-type="fig"}) and one evisceration). Other patients recovered with a normal-appearing posterior segment and no sign of recurrent infection.

Discussion
==========

Although colonization of skin and respiratory passages and contamination of indwelling lines and catheters are common events in the NICU, endophthalmitis is a rare complication. Most cases are caused by endogenous pathogens transmitted perinatally or during extended postnatal hospitalization. Historically, rates of endophthalmitis from septicemia approached 50%.[@b19-opth-6-733] These rates have been dropping over the last three decades from a reported incidence of 8.71 per 100,000 of live births per year in 1998 to only 4.42 per 100,000 in 2006.[@b12-opth-6-733] Improvements in recognition and earlier empiric use of broad-spectrum antibiotics and antifungals for septicemia have possibly reduced the rate of neonatal endophthalmitis to infants whose infection was not successfully controlled with intravenous therapies alone. Thus, in contrast with previously reported series, this cohort of patients required invasive vitreoretinal interventions for successful treatment of infection.

Infants in a NICU are at highest risk for septicemia and endophthalmitis. The presence of tunica vasculosa lentis may be an additional predisposing factor for endophthalmitis in very premature infants with septicemia. Infants with retinopathy of prematurity have increased vascular permeability because of upregulated vascular endothelial growth factor that may allow ocular seeding of septic emboli. Conversely, some authors have demonstrated an association between candidemia and progression to threshold retinopathy of prematurity.[@b20-opth-6-733],[@b21-opth-6-733]

The severity of endophthalmitis presentation in the current study may reflect timing of diagnosis relative to the onset of disease, the virulence of the causative pathogen, or a greater inoculum evading immune constraints. Examinations are routinely performed on premature and very low birth weight infants for retinopathy of prematurity.[@b22-opth-6-733] In addition, early ophthalmologic consultation is advisable in those infants with constitutional symptoms of septicemia or ocular signs, such as corneal edema or leukocoria.

In a study from our institution of endogenous fungal endophthalmitis in adults, 65 eyes of 51 patients were treated. Visual outcomes were poor, especially when the endophthalmitis was caused by mold.[@b23-opth-6-733] Similar to the adult population, the visual prognosis of neonatal endogenous endophthalmitis is often poor, even with early identification and prompt intervention.

Preparation of this article was supported by grant P30-EY014801 from the National Institutes of Health, Bethesda, MD, an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc, New York, NY, and the Heed Ophthalmic Foundation, Cleveland, Ohio (CCW).

**Disclosure**

Publication of this article was Supported by grant P30-EY014801 from the National Institutes of Health, Bethesda, Maryland; an unrestricted grant to the University of Miami from Research to Prevent Blindness Inc, New York, NY; and the Heed Ophthalmic Foundation, Cleveland, OH (CCW). Hassan A Aziz, MD: none. Audina M Berrocal, MD: Alcon. Robert A Sisk, MD: Allergan. Kristin Hartley, MD: none. Magaly Diaz-Barbosa, MD: none. Rose A Johnson, RN: none. Ditte Hess, CRA: none. Sander R Dubovy, MD: none. Timothy G. Murray, MD, MBA, FACS: Alcon. Harry W Flynn Jr, MD: Alcon, Allergan, Almiera, Pfizer.

![Fundus images of the right and left eyes of patient 4 with bilateral well circumscribed chorioretinal lesions in the macula. The lesion is more prominent in the right eye.](opth-6-733f1){#f1-opth-6-733}

![Montage image of the fundus of patient 6 showing diffuse necrotizing retinitis and vitritis.](opth-6-733f2){#f2-opth-6-733}

![(**A**) Gross image of the enucleated left eye of patient 3. (**B**) Gross image of the left eye with the superior cap removed; a retrocorneal tan white material with an admixture of hemorrhage is identified. (**C**) Histologic section of the left eye (Gomori methenamine silver 20×) showing fungal infiltrate.](opth-6-733f3){#f3-opth-6-733}

###### 

Clinical features in neonates with endophthalmitis in the neonatal intensive care unit

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient number/gender   Age of birth (gestational week)/birth weight (g)   Etiology                   Systemic treatment                                            Intravitreal injection   Interventional treatment                                                         Other ophthalmic findings
  ----------------------- -------------------------------------------------- -------------------------- ------------------------------------------------------------- ------------------------ -------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------
  1 (OD)/male             26 weeks/825 g                                     *Candida albicans*         Intravenous amphotericin B and fluconazole                    Amphotericin B           Pars plana vitrectomy/pars plana lensectomy with removal of pupillary membrane   Glaucoma[\*](#tfn2-opth-6-733){ref-type="table-fn"} in right eye with Baerveldt tube implant

  2 (OD)/female           25 weeks/870 g                                     *Candida albicans*         Intravenous amphotericin B and fluconazole                    Amphotericin B           Pars plana vitrectomy/pars plana lensectomy                                      Glaucoma[\*](#tfn2-opth-6-733){ref-type="table-fn"} in the right eye with Baerveldt tube implant\
                                                                                                                                                                                                                                                                                ROP in both eyes treated with laser ablative therapy

  3 (OS)/female           37 weeks/3340 g                                    *Candida albicans*         Intravenous fluconazole                                       Amphotericin B           Enucleation                                                                      Glaucoma[\*](#tfn2-opth-6-733){ref-type="table-fn"} in left eye (medically treated with acetazolamide)\
                                                                                                                                                                                                                                                                                ROP in right eye treated with laser ablative treatment

  4 (OD)/male             40 weeks/3225 g                                    *Candida albicans*         Intravenous amphotericin B, fluorocytosine, and fluconazole   Amphotericin B\          Pars plana vitrectomy/pars plana lensectomy                                      
                                                                                                                                                                      Voriconazole                                                                                              

  4 (OS)/male             40 weeks/3325 g                                    *Candida albicans*         Intravenous amphotericin B, fluorocytosine, and fluconazole   Amphotericin B                                                                                            

  5 (OD)/male             27 weeks/1000 g                                    *Pseudomonas aeruginosa*   Intravenous piperacillin, ceftazidime, and gentamicin                                  Evisceration                                                                     ROP

  6 (OD)/female           32 weeks/1910 g                                    *Herpes simplex* virus     Intravenous aciclovir                                                                                                                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

Glaucoma developed in patient 1 at age 2 years, in patient 2 at 3 months of age, and patient 3 was referred from an outside institution at 2 months of age with a diagnosis of congenital glaucoma.

**Abbreviation:** ROP, retinopathy of prematurity.
